Tap water from 497 properties using private water supplies, in an area of metalliferous and arsenic mineralisation (Cornwall, UK), was measured to assess the extent of compliance with chemical drinking water quality standards, and how this is influenced by householder water treatment decisions. The proportion of analyses exceeding water quality standards were high, with 65 % of tap water samples exceeding one or more chemical standards. The highest exceedances for health-based standards were nitrate (11 %) and arsenic (5 %). Arsenic had a maximum observed concentration of 440 µg/L. Exceedances were also high for pH (47 %), manganese (12 %) and aluminium (7 %), for which standards are set primarily on aesthetic grounds. However, the highest observed concentrations of manganese and aluminium also exceeded relevant health-based guidelines. Significant reductions in concentrations of aluminium, cadmium, copper, lead and/or nickel were found in tap waters where households were successfully treating low-pH groundwaters, and similar adventitious results were found for arsenic and nickel where treatment was installed for iron and/or manganese removal, and successful treatment specifically to decrease tap water arsenic concentrations was observed at two properties where it was installed. However, 31 % of samples where pH treatment was reported had pH < 6.5 (the minimum value in the drinking water regulations), suggesting widespread problems with system maintenance. Other examples of ineffectual treatment are seen in failed responses post-treatment, including for nitrate. This demonstrates that even where the tap waters are considered to be treated, they may still fail one or more drinking water quality standards. We find that the degree of drinking water standard exceedances warrant further work to understand environmental controls and the location of high concentrations. We also found that residents were more willing to accept drinking water with high metal (iron and manganese) concentrations than international guidelines assume. These findings point to the need for regulators to reinforce the guidance on drinking water quality standards to private water supply users, and the benefits to long-term health of complying with these, even in areas where treated mains water is widely available.Electronic supplementary materialThe online version of this article (doi:10.1007/s10653-016-9798-0) contains supplementary material, which is available to authorized users.
Private water supplies (PWS) in Cornwall, South West England exceeded the current WHO guidance value and UK prescribed concentration or value (PCV) for arsenic of 10 μg/L in 5% of properties surveyed (n = 497). In this follow-up study, the first of its kind in the UK, volunteers (n = 207) from 127 households who used their PWS for drinking, provided urine and drinking water samples for total As determination by inductively coupled plasma mass spectrometry (ICP-MS) and urinary As speciation by high performance liquid chromatography ICP-MS (HPLC-ICP-MS). Arsenic concentrations exceeding 10 μg/L were found in the PWS of 10% of the volunteers. Unadjusted total urinary As concentrations were poorly correlated (Spearman’s ρ = 0.36 (P < 0.001)) with PWS As largely due to the use of spot urine samples and the dominance of arsenobetaine (AB) from seafood sources. However, the osmolality adjusted sum, U-AsIMM, of urinary inorganic As species, arsenite (AsIII) and arsenate (AsV), and their metabolites, methylarsonate (MA) and dimethylarsinate (DMA), was found to strongly correlate (Spearman’s ρ: 0.62 (P < 0.001)) with PWS As, indicating private water supplies as the dominant source of inorganic As exposure in the study population of PWS users.
The risk of hospitalisation from bushfire exposure events in Darwin, Australia, is examined. Several local studies have found evidence for the effects of exposure to bushfire particulates on respiratory and cardiovascular hospital admissions. They have characterised the risk of admission from seasonal exposures to biomass air pollution. A new, unanalysed data set presented an additional chance to examine unique exposure effects, as there are no anthropogenic sources of particulates in the vicinity of the exposure monitor. The incidence of daily counts of hospital admissions for respiratory and cardiovascular diagnoses was calculated with respect to exposures of particulate matter (PM(10)), course particulate matter, fine particulate matter (FPM) and black carbon composition. A Poisson model was used to calculate unadjusted (crude) measures of effect and then adjusted for known risk factors and confounders. The final model adjusted for the effects of minimum temperature, relative humidity, a smoothed spline for seasonal effects, 'date' for a linear effect over time, day of the week and public and school holidays. A subset analysis adjusted for an influenza epidemic in a particular year. The main findings suggest that respiratory admissions were associated with exposure to PM(10) with a lag of 1 day when adjusted for flu and other confounders (RR = 1.025, 95 % CI 1.000-1.051, p < 0.05). This effect is strongest for exposure to FPM concentrations (RR = 1.091, 95 % CI 1.023-1.163, p < 0.01) when adjusted for flu. Respiratory admissions were also associated with black carbon concentrations recorded the previous day (RR = 1.0004, 95 % CI 1.000-1.0008, p < 0.05), which did not change strength when adjusted for flu. Cardiovascular admissions had the strongest association with exposure to same-day PM and highest RR for exposure to FPM when adjusted for confounders (RR = 1.044, 95 % CI 0.989-1.102). Consistent risks were also found with exposure to black carbon with lags of 0-3 days.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.